Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company applying its proprietary targeted protein degradation uSMITE™ platform to discover and advance therapeutics for the ...

Positive Phase 1b Data Confirms Overdose Protection for Highest Dosage Form of PF614-MPAR ~ SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 /, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a ...

Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...

A National Academies consensus study committee funded by the Social Security Administration will host the second in a series ...

Now, more research is emerging looking at ultrasound as a pain reliever. "We use it almost like a stethoscope in the ...

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

We had confidantes, and now we talk about contacts that we have online,” Murthy said. "But how many people are there to show ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of ...

Chronic pain remains a significant challenge around the world, while traditional treatments like opioids and physical therapy ...

Under a new state pilot, paramedics in Kitsap County will start administering a medication that blunts withdrawals and cravings.

Clinicians and policymakers need a more accurate estimate of the prevalence of problematic opioid use, authors say.